Digestive Diseases and Sciences

, Volume 54, Issue 10, pp 2161–2166 | Cite as

Ghrelin and Obestatin Levels in Type 2 Diabetic Patients With and Without Delayed Gastric Emptying

  • Igor A. Harsch
  • Corinna Koebnick
  • Atingwa M. Tasi
  • Eckhart Georg Hahn
  • Peter C. Konturek
Original Article


Alterations in the neurohumoral regulation of the upper intestine may change rhythmicity and pattern of ghrelin and obestatin, the latter presumably antagonizing ghrelin effects. Five nongastroparetic diabetic patients and five with gastroparesis were investigated. Over 390 min including breakfast and lunch, ghrelin was significantly lower in patients with gastroparesis compared with in those without (P = 0.015). Ghrelin subsequent to lunch decreased significantly (P = 0.011) in patients without gastroparesis, but not in gastroparetic patients (P = 0.669). Obestatin was similar in both groups and unchanged. No significant differences in ghrelin-to-obestatin ratio were observed (P = 0.530). Loss of rhythmicity in the ghrelin levels of gastroparetic diabetics highlights the importance of integrity of the neurohumoral-intestinal axis. Stable diurnal obestatin levels do not support the concept of interaction between ghrelin and obestatin in terms of regulation of food intake and gastric emptying.


Ghrelin Obestatin Diabetes mellitus Gastroparesis 


  1. 1.
    Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–1630.PubMedCrossRefGoogle Scholar
  2. 2.
    Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing alcylated peptide is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–4261. doi: 10.1210/en.141.11.4255.PubMedCrossRefGoogle Scholar
  3. 3.
    Korbonits M, Grossman AB. Ghrelin: update on a novel hormonal system. Eur J Endocrinol. 2004;151(Suppl 1):S67–S70. doi: 10.1530/eje.0.151S067.PubMedCrossRefGoogle Scholar
  4. 4.
    Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93:210–215. doi: 10.1002/bjs.5227.PubMedCrossRefGoogle Scholar
  5. 5.
    Vincent RP, le Roux CW. Changes in gut hormones after bariatric surgery. Clin Endocrinol (Oxf). 2008;69(2):173–179.CrossRefGoogle Scholar
  6. 6.
    DeBlock CEM, De Leeuw IH, Pelckmans PA, Callens D, Maday E, Van Gaal LF. Delayed gastric emptying and gastric autoimmunity in type 1 diabetes. Diabetes Care. 2002;25:912–917. doi: 10.2337/diacare.25.5.912.CrossRefGoogle Scholar
  7. 7.
    Feldmann M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 1983;98:378–384.Google Scholar
  8. 8.
    Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science. 2005;310:996–999.PubMedCrossRefGoogle Scholar
  9. 9.
    de Smet B, Thijs T, Peeters TL, Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol Motil. 2007;19:211–217. doi: 10.1111/j.1365-2982.2006.00883.x.PubMedCrossRefGoogle Scholar
  10. 10.
    Bassil AK, Haglund Y, Brown J, et al. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br J Pharmacol. 2007;150:58–64. doi: 10.1038/sj.bjp.0706969.PubMedCrossRefGoogle Scholar
  11. 11.
    Qiu WC, Wang ZG, Wang WG, et al. Gastric motor effects of ghrelin and growth hormone releasing peptide 6 in diabetic mice with gastroparesis. World J Gastroenterol. 2008;14:1419–1424. doi: 10.3748/wjg.14.1419.PubMedCrossRefGoogle Scholar
  12. 12.
    Guo ZF, Zheng X, Qin YW, Hu JQ, Chen SP, Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab. 2007;92:1875–1880. doi: 10.1210/jc.2006-2306.PubMedCrossRefGoogle Scholar
  13. 13.
    Erdmann J, Lippl F, Wagenpfeil S, Schusdziarra V. Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes. Diabetes. 2005;54:1371–1378. doi: 10.2337/diabetes.54.5.1371.PubMedCrossRefGoogle Scholar
  14. 14.
    Gaddipati KV, Simonian HP, Kresge KM, Boden GH, Parkman HP. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci. 2006;51:1339–1346. doi: 10.1007/s10620-005-9022-z.PubMedCrossRefGoogle Scholar
  15. 15.
    Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol. 2008;36:44–54. doi: 10.2967/jnmt.107.048116.PubMedCrossRefGoogle Scholar
  16. 16.
    Soares JB, Leite-Moreira AF. Ghrelin, des-acyl ghrelin and obestatin: Three pieces of the same puzzle. Peptides. 2008;29:1255–1270. doi: 10.1016/j.peptides.2008.02.018.PubMedCrossRefGoogle Scholar
  17. 17.
    Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001;120:337–345. doi: 10.1053/gast.2001.22158.PubMedCrossRefGoogle Scholar
  18. 18.
    Levin F, Edholm T, Schmidt PT, et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab. 2006;91:3296–3302. doi: 10.1210/jc.2005-2638.PubMedCrossRefGoogle Scholar
  19. 19.
    Ueno H, Shiiya T, Mizuta M, Mondal SM, Nakazato M. Plasma ghrelin concentrations in different clinical stages of diabetic complications and glycemic control in Japanese diabetics. Endocr J. 2007;54:895–902. doi: 10.1507/endocrj.K07-007.PubMedCrossRefGoogle Scholar
  20. 20.
    Ariyasu H, Takaya K, Hosoda H, et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology. 2002;143:3341–3350. doi: 10.1210/en.2002-220225.PubMedCrossRefGoogle Scholar
  21. 21.
    Zamrazilová H, Hainer V, Sedláčková D, et al. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res. 2008;57(Suppl 1):S49–S55.PubMedGoogle Scholar
  22. 22.
    Anderwald-Stadler M, Krebs M, Promintzer M, et al. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab. 2007;293:E1393–E1398.PubMedCrossRefGoogle Scholar
  23. 23.
    Granata R, Settanni F, Gallo D, et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes. 2008;57(4):967–979.PubMedCrossRefGoogle Scholar
  24. 24.
    Szentirmai E, Krueger JM. Obestatin alters sleep in rats. Neurosci Lett. 2006;404:222–226. doi: 10.1016/j.neulet.2006.05.053.PubMedCrossRefGoogle Scholar
  25. 25.
    Carlini VP, Schiöth HB, Debarioglio SR. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun. 2007;352:907–912. doi: 10.1016/j.bbrc.2006.11.112.PubMedCrossRefGoogle Scholar
  26. 26.
    Camina JP, Campos JF, Caminos JE, Dieguez C, Casanueva FF. Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. J Cell Physiol. 2007;211:1–9. doi: 10.1002/jcp.20925.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Igor A. Harsch
    • 1
  • Corinna Koebnick
    • 2
  • Atingwa M. Tasi
    • 3
  • Eckhart Georg Hahn
    • 4
  • Peter C. Konturek
    • 4
  1. 1.Department of Medicine 1, Division of Endocrinology and MetabolismFriedrich-Alexander University Erlangen-NurembergErlangenGermany
  2. 2.Department of Research and EvaluationSouthern California Permanente Medical GroupPasadenaUSA
  3. 3.Department of SurgeryKlinikum Lippe-DetmoldDetmoldGermany
  4. 4.Department of Medicine 1Friedrich-Alexander University Erlangen-NurembergErlangenGermany

Personalised recommendations